Feed NAOV
NA

NanoVibronix, Inc.

NAOV · NASDAQ

$1.90 +1.06% (+$0.02)
Piotroski F-Score Weak
0/9
Valuation
-
N/A
P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A
EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A
Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A
ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A
Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
0 /100
Unstable
Beta 2.06x
Rev. volatility N/A
EPS volatility N/A

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o NAOV
Online

O podjetju

NanoVibronix (NVCN) is a company focused on the development and commercialization of innovative medical devices utilizing ultrasound technology. With a product portfolio including PainShield®, NanoVibronix is a pioneer in the field of ultrasound therapy for the treatment of various conditions and ailments. PainShield® is a portable device designed to treat pain and inflammation using ultrasound vibrations applied to the affected area. The company also focuses on other applications of ultrasound technology in areas such as regenerative therapies, drainage procedures, and infection prevention. With growing interest in non-invasive therapeutic methods and the need for innovative treatment approaches, NanoVibronix has the potential for further development and expansion in the market. NanoVibronix (NVCN) shares could be suitable for investors seeking exposure in the medical technology field with a focus on ultrasound therapy and innovative treatment approaches.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Doron Robert Besser

Employees

31

Headquarters

Elmsford

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.